Sean Scanlan
Fortuna: 799 025 $ al 30/06/2026
Fortuna: 799 025 $ al 30/06/2026
Sean F.
Scanlan is Chief Innovation & Marketing Officer at Treace Medical Concepts, Inc. since 2026.
Formerly, Dr. Scanlan was Principal at Smith & Nephew plc from 2011 to 2014.
Education includes graduate and doctorate degrees from Stanford University and an undergraduate degree from the University of Florida.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 23/03/2026 | 200.760 ( 0,31 % ) | 799 025 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. | Ventas & Marketing | 01/04/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| SMITH & NEPHEW PLC | Corporate Officer/Principal | 01/04/2014 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Smith & Nephew plc
Smith & Nephew plc Medical SpecialtiesHealth Technology Develops, manufactures and markets medical technology devices | Health Technology |
Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. Medical SpecialtiesHealth Technology Manufactures and sells orthopedic medical devices | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.